Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients

By Domingo Christian   Moreno Amalia   José Amengual Ma   Montón Concepción   Suárez David   Pomares Xavier  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 45-53

Informa Healthcare

Access to resources Recommend Favorite

Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

By Siergiejko Zenon   ŚŚwiebocka Ewa   Smith Nicola   Peckitt Clare   Leo Jo   Peachey Guy   Maykut Robert  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2223-2228

Informa Healthcare

Access to resources Recommend Favorite

Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis

By Busse William W.   Massanari Marc   Kianifard Farid   Geba Gregory P.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2379-2386

Informa Healthcare

Access to resources Recommend Favorite

Improvement in quality of life with omalizumab in patients with severe allergic asthma

By Chipps Bradley   Buhl Roland   Beeh Kai-Michael   Fox Howard   Thomas Karen   Reisner Colin  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2201-2208

Informa Healthcare

Access to resources Recommend Favorite

Step-Down and Step-Up Therapy in Moderate Persistent Asthma

By  

International Archives of Allergy and Immunology, Vol. 124, Iss. 1-3, 2012-01 ,pp. : 414-416

Karger

Access to resources Recommend Favorite